School of Applied Sciences, University of Campinas, Limeira, São Paulo, Brazil.
Laboratory of Investigation on Metabolism and Diabetes, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
Endocrine. 2023 Jun;80(3):529-540. doi: 10.1007/s12020-023-03356-0. Epub 2023 Apr 8.
The gut microbiome is associated with obesity, mainly mediated by bacteria-produced short-chain fatty acids (SCFAs). It is unknown how SCFA concentrations are associated with the phenotypes metabolically healthy normal weight (MHNW), metabolically unhealthy normal weight (MUNW), metabolically healthy obese/overweight (MHO), and metabolically unhealthy obese/overweight (MUO). We compared plasma and fecal SCFA concentrations among adult women categorized according to the metabolic phenotypes mentioned above and examined associations between SCFA and adiposity and components of energy and glucose homeostasis.
This was a cross-sectional study involving 111 participants. Body composition was assessed by DEXA. Energy and glycemic homeostasis were assessed by the standard mixed-meal tolerance test coupled with indirect calorimetry. SCFAs were quantified by gas chromatography and mass spectrometry.
Only plasma propionate was increased in the MHNW phenotype compared to the MHO and MUO phenotypes [p < 0.05]. Fecal propionate and butyrate concentrations and plasma propionate concentrations were inversely associated with total and visceral adiposity [p < 0.05]. Fecal and plasma SCFA concentrations were associated with reduced glucose, insulin and HbA1c levels, increased fasting and postprandial GLP-1 levels; and more preserved beta-cell function [p < 0.05]. Fecal and plasma SCFA concentrations were positively correlated with resting energy expenditure and lipid oxidation rate and inversely correlated with the oxidation rate of carbohydrates [p < 0.05].
These findings reinforce the concept that fecal and plasma SCFA concentrations are linked to specific components of energy and glucose homeostasis; and body adiposity. However, it was not possible to discriminate the different metabolic phenotypes of adiposity based on the determination of fecal SCFA concentrations.
肠道微生物群与肥胖有关,主要通过细菌产生的短链脂肪酸(SCFAs)介导。目前尚不清楚 SCFA 浓度与代谢健康正常体重(MHNW)、代谢不健康正常体重(MUNW)、代谢健康肥胖/超重(MHO)和代谢不健康肥胖/超重(MUO)这些表型有何关联。我们比较了根据上述代谢表型分类的成年女性的血浆和粪便 SCFA 浓度,并研究了 SCFA 与肥胖和能量及葡萄糖稳态成分之间的关联。
这是一项横断面研究,涉及 111 名参与者。DEXA 评估身体成分。标准混合餐耐量试验结合间接测热法评估能量和血糖稳态。通过气相色谱和质谱法定量 SCFA。
与 MHO 和 MUO 表型相比,MHNW 表型的血浆丙酸盐仅增加[P < 0.05]。粪便丙酸盐和丁酸盐浓度以及血浆丙酸盐浓度与总脂肪和内脏脂肪呈负相关[P < 0.05]。粪便和血浆 SCFA 浓度与降低的血糖、胰岛素和 HbA1c 水平、增加的空腹和餐后 GLP-1 水平相关;以及更好的β细胞功能[P < 0.05]。粪便和血浆 SCFA 浓度与静息能量消耗和脂质氧化率呈正相关,与碳水化合物氧化率呈负相关[P < 0.05]。
这些发现强化了这样一个概念,即粪便和血浆 SCFA 浓度与能量和葡萄糖稳态的特定成分以及身体脂肪有关。然而,根据粪便 SCFA 浓度的测定,无法区分不同的肥胖代谢表型。